Aurobindo Pharma Acquires 26% Stake in Solar Firm, Executes Captive Power Agreement

The latest development is in continuation of the company's earlier disclosures dated February 6, 2025, March 28, 2025, June 30, 2025, September 26, 2025, December 30, 2025 and March 30, 2026, through which it had informed the stock exchanges about the proposed execution of a power purchase agreement with Swarnaakshu Solar Power Private Limited for the procurement of solar power under Telangana's captive power policy and its proposed investment of up to Rs. 10.40 crore for acquiring 26% of the paid-up equity share capital and other securities of the company.

The filing states that on June 25, 2026, Aurobindo Pharma made an initial investment of Rs 52 lakh, following which it acquired 26% of the equity share capital of Swarnaakshu Solar Power Private Limited.

The company further informed that it has executed the power purchase agreement with Swarnaakshu for the procurement of solar power for captive consumption, in line with its previously announced plans.

Aurobindo Pharma also stated that the balance investment out of the proposed Rs. 10.40 crore will be made from time to time, depending on the progress of the solar project and the fund requirements of Swarnaakshu Solar Power Private Limited. According to the Aurobindo Pharma regulatory filing, the acquisition of a 26% equity stake, the execution of the solar power purchase agreement and the phased investment are part of the company's captive renewable energy initiative under the Government of Telangana's captive power policy. The filing reiterates that the remaining investment will be infused based on the progress of the project and the funding requirements of the solar power company.

Also Read: Aurobindo's Eugia Unit-I Receives OAI Classification After 4 USFDA Observations